Longeveron (LGVN) stock forecast for 2023
Last update: 05-13-2022, 5:32Sector: Healthcare
The share price of Longeveron Inc. (LGVN) now
What analysts predict:: $18
52-week high/low: $45 / $2.84
50/200 Day Moving Average: $8.78 / $8.12
This figure corresponds to the average price over the previous 50/200 days. For Longeveron stocks, the 50-day moving average is the resistance level today.
For Longeveron stocks, the 200-day moving average is the support level today.
Are you interested in Longeveron stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Longeveron stock price in 2023. How much will one Longeveron share be worth in 2023?
Is it worth taking profit / loss on Longeveron stock now or waiting? What are analysts' forecasts for Longeveron stock?
We forecast Longeveron stock performance using neural networks based on historical data on Longeveron stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
The Longeveron stock prediction results are shown below and presented as a graph, table and text information.
Longeveron stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Longeveron analysts is $18.
Today 200 Day Moving Average is the support level (8.12 $).
50 Day Moving Average is the resistance level (8.78 $).
Historical and forecast chart of Longeveron stock
The chart below shows the historical price of Longeveron stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Longeveron stock price can be found in the table below.
Longeveron (LGVN) Forecast for 2023
Longeveron information and performance
Longeveron LLC is a clinical stage biotechnology company that engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. The company was founded by Joshua M. Hare and Donald M. Soffers in October 9, 2014 and is headquartered in Miami, FL.
1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL, US
Market Capitalization: 146 590 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: - $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: None
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: -0.823
Trailing PE: -
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: -
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 109.59
Enterprise Value (EV) /Revenue
EV To EBITDA: -
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 5326500
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
Longeveron price target for 2021 by month
Target values for the price of one Longeveron share for Jan 2023.
Pessimistic target level: 5.33
Optimistic target level: 6.60
Target values for the price of one Longeveron share for Feb 2023.
Pessimistic target level: 5.23
Optimistic target level: 6.39
Target values for the price of one Longeveron share for Mar 2023.
Pessimistic target level: 4.91
Optimistic target level: 5.90
Target values for the price of one Longeveron share for Apr 2023.
Pessimistic target level: 3.83
Optimistic target level: 4.93
Target values for the price of one Longeveron share for May 2023.
Pessimistic target level: 4.26
Optimistic target level: 5.08
Target values for the price of one Longeveron share for Jun 2023.
Pessimistic target level: 3.91
Optimistic target level: 4.68
Target values for the price of one Longeveron share for Jul 2023.
Pessimistic target level: 4.43
Optimistic target level: 5.66
Target values for the price of one Longeveron share for Aug 2023.
Pessimistic target level: 4.33
Optimistic target level: 5.06
Target values for the price of one Longeveron share for Sep 2023.
Pessimistic target level: 4.41
Optimistic target level: 4.96
Target values for the price of one Longeveron share for Oct 2023.
Pessimistic target level: 5.22
Optimistic target level: 6.35
Target values for the price of one Longeveron share for Nov 2023.
Pessimistic target level: 6.02
Optimistic target level: 6.76
Target values for the price of one Longeveron share for Dec 2023.
Pessimistic target level: 5.96
Optimistic target level: 7.10
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.